v3.26.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Non-Voting Convertible Preferred Stock
Series B
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balances at Dec. 31, 2024 $ 2,931 $ 37 $ 463,018 $ (41) $ (83,724) $ 382,221
Balances (in Shares) at Dec. 31, 2024 137,138 37,440,510        
Stock-based compensation expense 3,468 3,468
Unrealized gains (losses) on marketable securities 35 35
Net loss (20,999) (20,999)
Balances at Mar. 31, 2025 $ 2,931 $ 37 466,486 (6) (104,723) 364,725
Balances (in Shares) at Mar. 31, 2025 137,138 37,440,510        
Balances at Dec. 31, 2025 $ 2,931 $ 49 657,561 546 (189,157) 471,930
Balances (in Shares) at Dec. 31, 2025 137,138 48,722,309        
Issuance of common stock upon exercise of stock options and employee warrants 1,766 1,766
Issuance of common stock upon exercise of stock options and employee warrants (in Shares)   195,596        
Issuance of common stock under the at-the-market (“ATM”) offering program, net of commissions $ 1 38,901 38,902
Issuance of common stock under the at-the-market (“ATM”) offering program, net of commissions (in Shares)   1,167,895        
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon vesting of restricted stock units (in Shares)   24,611        
Issuance of common stock upon exercise of prefunded warrants
Issuance of common stock upon exercise of prefunded warrants (in Shares)   57,212        
Stock-based compensation expense 6,968 6,968
Unrealized gains (losses) on marketable securities (1,026) (1,026)
Net loss         (31,820) (31,820)
Balances at Mar. 31, 2026 $ 2,931 $ 50 $ 705,196 $ (480) $ (220,977) $ 486,720
Balances (in Shares) at Mar. 31, 2026 137,138 50,167,623